Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Restenosis
Radiation Prevents Artery Closing After Angioplasty and Stenting
September 3rd, 2000
A clinical trial on a procedure that delivers radiation to arteries to prevent them from re-closing after patients are treated with angioplasty and stenting has been so successful that the U.S. Food and Drug Administration (FDA) announced that the trial can be expanded. Cardiologists at Rush-Presbyterian-St. Luke's Medical Center, who were among the original investigators in the clinical trial, can treat all patients who met the enrollment criteria for the clinical trial with the low-dose radiation. In the clinical trial begun two years ago, patients enrolled were given either radiation or standard angioplasty to treat arteries that reclosed...
Source: Medical Letter on the CDC & FDA (2000-09-03)
|
